|
Spain Pharmaceuticals News. Service for global professionals. Constantly updated news and information about Spain.
Latest Spain Pharmaceuticals News
- Ipsen's Decapeptyl® 6-Month Formulation Receives Marketing Authorization in France for the Treatment of Locally Advanced 13 Nov 2009 06:33 GMT
... News. Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities ... state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands while for other European countries ... so required by applicable law. The Group’s business is subject to the risk factors outlined ...
- Faes Farma signs licensing agreement with Pfizer to market 13 Nov 2009 13:57 GMT
... Faes Farma signs licensing agreement with Pfizer to market MADRID, 12th of November, 2009 -FAES FARMA has ... licensing agreement with PFIZER,; the world’s leading biopharmaceutical company. Under the terms of the; agreement, ...
- Ipsen's Decapeptyl(R) 6-Month Formulation Receives Marketing Authorization in France for the Treatment of Locally Advanced or Metastatic Prostate Cancer 13 Nov 2009 06:11 GMT
... Metastatic Prostate Cancer PARIS, Nov 13, 2009 (BUSINESS WIRE) -- Ipsen (Paris:IPN), an innovation-driven global ... -- Ipsen (Paris:IPN), an innovation-driven global specialty pharmaceutical Group announces that the French regulatory authorities ... state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands while for other European countries ...
- Ipsen's Decapeptyl® 6-Month Formulation Receives Marketing Authorization in France for the Treatment of Locally Advanced or Metastatic Prostate Cancer 13 Nov 2009 06:30 GMT
... state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands while for other European countries ... Switzerland. Ipsen is an innovation-driven global specialty pharmaceutical group with over 20 products on the ... so required by applicable law. The Group's business is subject to the risk factors outlined ...
- Ipsen's Decapeptyl 6-Month Formulation Receives Marketing Authorization in France for the Treatment of Locally Advanced 13 Nov 2009 06:32 GMT
... state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands while for other European countries ... Switzerland. Ipsen is an innovation-driven global specialty pharmaceutical group with over 20 products on the ... so required by applicable law. The Group's business is subject to the risk factors outlined ...
- Ipsen's Decapeptyl 6-Month Formulation Receives Marketing Authorization in France for the Treatment of Locally Advanced or Metastatic Prostate Cancer 13 Nov 2009 21:36 GMT
... state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands while for other European countries ... Switzerland. Ipsen is an innovation-driven global specialty pharmaceutical group with over 20 products on the ... so required by applicable law. The Group's business is subject to the risk factors outlined ...
- FAES FARMA signs licensing agreement with Pfizer for Bilastine Deal In Brief 13 Nov 2009 19:30 GMT
... FAES FARMA signs licensing agreement with Pfizer for Bilastine ... COMTEX News Network) -- FAES FARMA, a Spanish pharmaceutical company, has signed a licensing agreement with ...
- How U.N. redefined 'pandemic' to heighten alarm over H1N1 13 Nov 2009 12:11 GMT
... and public health officials, virologists and the pharmaceutical companies. They've built this machine around the ... where the big money from the pharmaceuticals industry is. It makes sure that research on ... the monastery of Sant Benet, in Montserrat-Barcelona, Spain, is a physician specializing in internal medicine ...
- World Health Organization quietly changed qualification of term in case of 'swine flu' 13 Nov 2009 12:11 GMT
... and public health officials, virologists and the pharmaceutical companies. They've built this machine around the ... where the big money from the pharmaceuticals industry is. It makes sure that research on ... the monastery of Sant Benet, in Montserrat-Barcelona, Spain, is a physician specializing in internal medicine ...
- Good end to the day and week 13 Nov 2009 17:34 GMT
... Market Movers FTSE 100 5,296.38 +0.38% techMARK 1,507.32 ... assesses terms of its proposed merger with Spanish airline Iberia. BA will own 55% of the ... both companies' head offices in London and Madrid. But there are concerns that BA’s pension ...
- Champions Biotechnology to Present Data at AACR-EORTC 2009 Regarding the Predictability of Biomerk Tumorgraft(TM) Platform to Guide Personalized Cancer Treatment and Accelerate Oncology Drug Development 13 Nov 2009 04:30 GMT
... Clinical Research Program at CNIO all in Madrid, Spain and Champions' Chief Scientist will present data regarding ... to sell, partner or license them to pharmaceutical and/or biotechnology companies, as appropriate. The Company ...
- European Stocks Set For Weak Start 13 Nov 2009 07:54 GMT
... (RTTNews) - The European markets may open lower ... In corporate news, British Airways Plc and Spanish airline Iberia Lineas Aereas de Espana SA ... entered into a binding agreement with Barr Pharmaceuticals LLC and Barr Laboratories, Inc. to settle ...
- New Center For Cardiac Safety And Innovation Launched By URMC 13 Nov 2009 09:02 GMT
... together an international network of academic researchers, pharmaceutical and medical device companies, and government regulators. ... together and made available to academic and industry researchers," said Couderc. "At the same time, ... Republic, and the University of Zaragoza in Spain. Source: Mark Michaud University of Rochester Medical ...
- Enzon Announces Agreement to Sell Specialty Pharmaceutical Business 9 Nov 2009 13:55 GMT
... Enzon Announces Agreement to Sell Specialty Pharmaceutical Business sigma-tau to acquire business for approximately ... programs utilize several cutting-edge approaches, including its industry-leading PEGylation technology platform and the Locked Nucleic ... USA and India, as well as in Spain and Sudan where the Group operates two production ...
- EpiCept Corporation Reports Third Quarter Results, Provides Business Update 10 Nov 2009 05:33 GMT
... EpiCept Corporation Reports Third Quarter Results, Provides Business Update Conference Call Begins at 9:00 A.M. ... sites in Sweden, Belgium, France, the U.K., Spain and Italy. The two primary objectives of the ... exclusive, worldwide development and commercialization agreement. Myriad Pharmaceuticals, Inc., a public company formed from a ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
14 November 2009
13 November 2009
12 November 2009
|
a digital news provider
google.com:
cbsnews.com:
telegraph.co.uk:
bbc.co.uk: